Identification of genomic changes associated with cisplatin resistance in testicular germ cell tumor cell lines.
Since the introduction of cisplatin into the clinic, the treatment of patients with a variety of solid tumors including testicular germ cell tumors, ovarian and lung cancers, has dramatically improved. One of the main causes for therapeutic failure in these malignancies is the development of drug re...
Главные авторы: | Noel, E, Perry, J, Chaplin, T, Mao, X, Cazier, J, Joel, S, Oliver, RT, Young, B, Lu, Y |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2008
|
Схожие документы
-
Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors
по: André van Helvoort Lengert, и др.
Опубликовано: (2022-08-01) -
Testicular germ cell tumors
по: Peter Albers
Опубликовано: (2021-04-01) -
Immunotherapy in Testicular Germ Cell Tumors
по: Katarina Kalavska, и др.
Опубликовано: (2020-09-01) -
Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
по: Meineke Viktor, и др.
Опубликовано: (2011-05-01) -
p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.
по: Matthias Gutekunst, и др.
Опубликовано: (2011-01-01)